The US Supreme Court has ruled in favor of Bayer in a challenge related to litigation over its Roundup product. The ruling appears to limit or block certain lawsuits against the company, specifically those related to cancer claims. The decision has had a positive impact on Bayer's shares, but its exact implications for ongoing lawsuits and the company's business structure are still being assessed.